Menu
Our Mission
We care about improving the quality of life and strengthening the health of millions of people, by producing effective, safe, quality and affordable products.
SKU (Stock Keeping Unit)
Today in Company’s portfolio there are more than 440 items, including original combined preparations to be applied in dermatology, gynecology, otolaryngology, cardiology, elimination of flu and cold symptoms, fungal nail infections, without any currently available analogues. And also there are remedy brands and generics, and cosmetic brands products.
№1
the company's first
completed facility
For two years the Company has built the Innovation and Production Complex of the total area of about 21,000 m², and began the production of remedies in 2015.
Since 2018 the Company has implemented projects of the second and third stages of the facility.
In 2019 the laboratory and warehouse block, with a total area of around 7,300 m² (the second stage), started its operation. At the end of the same year, WERTEKS fully put the pharmaceutical complex with a total area 56,500 m², taking into consideration the third stage with an area of more than 28,000 m² into operation.
Since 2018 the Company has implemented projects of the second and third stages of the facility.
In 2019 the laboratory and warehouse block, with a total area of around 7,300 m² (the second stage), started its operation. At the end of the same year, WERTEKS fully put the pharmaceutical complex with a total area 56,500 m², taking into consideration the third stage with an area of more than 28,000 m² into operation.
SINCE 2010
We are in the top 10 domestic manufacturers that have had the greatest impact on the development of the Russian pharmaceutical market since 2010, and have reached 6th place in 2024 (Bionika Media Innovations)
№ 1
in terms of market share among Russian pharmaceutical manufacturers in the pharmacy market of antibiotics in the Russian Federation, which are recommended by the Ministry of Health of Russia in case of complications associated with COVID-19(data from analytical company AlphaRM, Q1-Q3 2020 in value terms)
Innovations
6
original combined medicinal products without any analogues available
Area of use: gynecology, dermatology, cardiology, otolaryngology, elimination of flu and cold symptoms, fungal nail infections
100+
products at the development and registration stages
Original combination drugs, generics and cosmetics
3
original drugs
at the development stage
at the development stage
Recognition
We regularly receive a high outside assessment of our work for economic indicators, production development, innovations, quality and efficiency of top management work – both from expert and business societies. Our Company and products are constantly included into the ratings of maximum values and growth. The achievements are acknowledged by regional and federal official bodies.
Winner of the Russian Governmental Award for Quality, 2017.
The backbone enterprise of St. Petersburg and
Russia
2020
Certificates of Acknowledgement from the Russian Ministry of Industry and Trade, 2017
For great contribution to the development of the pharmaceutical industry.
Cooperation
Company is in cooperation with federal and regional authorities, entities, structures, among them: the Russian Ministry of Industry and Trade, the Russian Ministry of Economic Development, the Russian Ministry of Health, Saint-Petersburg Government, Special Economic Zones, and others. Company is included into industrial groups and interacts with leading high educational institutions. Among our commercial partners are 6 pharmaceutical distributors. Altogether, the products are represented in more than 70.000 pharmacies.
